Serum MCP-1 levels are increased in mild cognitive impairment and mild Alzheimer's disease

Neurobiology of Aging

Volumn 27, Issue 12, 2006, Pages 1763-1768

  Galimberti, Daniela ^a   Fenoglio, Chiara ^a   Lovati, Carlo ^b   Venturelli, Eliana ^a   Guidi, Ilaria ^a   Corrà, Barbara ^a   Scalabrini, Diego ^a   Clerici, Francesca ^b   Mariani, Claudio ^b   Bresolin, Nereo ^a   Scarpini, Elio ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

Alzheimer's disease (AD); Biomarker; Mild cognitive impairment (MCI); Monocyte chemoattractant protein 1 (MCP 1)

Indexed keywords

MONOCYTE CHEMOTACTIC PROTEIN 1;

AGED; ALZHEIMER DISEASE; ARTICLE; CLINICAL FEATURE; COGNITIVE DEFECT; CONTROLLED STUDY; EVALUATION; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION;

AGED; ALZHEIMER DISEASE; BIOLOGICAL MARKERS; CHEMOKINE CCL2; COGNITION DISORDERS; FEMALE; HUMANS; MALE; UP-REGULATION;

EID: 33749998363     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2005.10.007     Document Type: Article

References (38)

1. Akiyama H., Barger S., Barnum S., Bradt B., Bauer J., Cole G.M., et al. Inflammation and Alzheimer's disease. Neurobiol Aging 21 (2000) 383-421
2. Adams J.M., and Cory S. The Bcl-2 protein family: arbiters of cell survival. Science 281 (1998) 1322-1326
3. Boehme S.A., Lio F.M., Maciejewski-Lenoir D., Bacon K.B., and Conlon P.J. The chemokine fractalkine inhibits Fas-mediated cell death in brain microglia. J Immunol 65 (2000) 397-403
4. Corder E.H., Saunders A.M., Strittmatter W.J., Schmechel D.E., Gaskell P.C., Small G.W., et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261 (1993) 921-923
5. Dai C., and Krantz S.B. Interferon γ induces upregulation and activation of caspases 1, 3 and 8 to produce apoptosis in human erythroid progenitor cells. Blood 93 (1999) 3309-3316
6. Del Bo R., Comi G.P., Bresolin N., Castelli E., Conti E., Degiuli A., et al. The apolipoprotein E ε4 allele causes a faster decline of cognitive performances in Down's syndrome subjects. J Neurol Sci 145 (1997) 87-91
7. Fenoglio C., Galimberti D., Lovati C., Guidi I., Gatti A., Fogliarino S., et al. MCP-1 in Alzheimer's disease patients: A-2518G polymorphism and serum levels. Neurobiol Aging 25 (2004) 1169-1173
8. Fuentes M.E., Durham S.K., Swerdel M.R., Lewin A.C., Barton D.S., Megill J.R., et al. Controlled recruitment of monocytes and macrophages to specific organs through transgenic expression of monocyte chemoattractant protein-1. J Immunol 155 (1995) 5769-5776
9. Galimberti D., Schoonenboom N., Scarpini E., and Scheltens P. On behalf of the Dutch-Italian Alzheimer Research Group. Chemokines in serum and cerebrospinal fluid of Alzheimer's disease patients. Ann Neurol 53 4 (2003) 547-548
10. Galimberti D, Schoonenboom N, Scheltens P, Fenoglio C, Venturelli E, Pijnenburg YAL, et al. Intrathecal chemochine levels in Alzheimer's disease and Frontotemporal Lobar Degeneration. Neurology, in press.
11. Gu L., Rutledge B., Fiorillo J., Ernst C., Grewal I., Flavell R., et al. In vivo properties of monocyte chemoattractant protein-1. J Leukocyte Biol 62 (1997) 577-580
12. Guidi I., Galimberti D., Lonati S., Novembrino C., Bamonti F., Tiriticco M., et al. Oxidative imbalance in patients with mild cognitive impairment and Alzheimer's disease. Neurobiol Aging 27 (2006) 262-269
13. Gunn M.D., Nelken N.A., Liao X., and Williams L.T. Monocyte chemoattractant protein-1 is sufficient for the chemotaxis of monocytes in transgenic mice but requires an additional stimulus for inflammatory activation. J Immunol 158 (1997) 376-383
14. Henkel J.S., Engelhardt J.I., Siklos L., Simpson E.P., Kim S.H., Pan T., et al. Presence of dendritic cells, MCP-1, and activated microglia/macrophages in amyotrophic lateral sclerosis spinal cord tissue. Ann Neurol 55 2 (2004) 221-235
15. Inadera H., Egashira K., Takemoto M., Ouchi Y., and Matsushima K. Increase in circulating levels of monocyte chemoattractant protein-1 with aging. J Interf Cytokine Res 19 (1999) 1179-1182
16. Ishizuka K., Kimura T., Igata-yi R., Katsuragi S., Takamatsu J., and Miyakawa T. Identification of monocyte chemoattractant protein-1 in senile plaques and reactive microglia of Alzheimer's disease. Psychiatry Clin Neurosci 1 (1997) 135-138
17. Kalehua A.N., Nagel J.E., Whelchel L.M., Gides J.J., Pyle R.S., Smith R.J., et al. Monocyte chemoattractant protein-1 and macrophage inflammatory protein-2 are involved in both excitotoxin-induced neurodegeneration and regeneration. Exp Cell Res 297 (2004) 197-211
18. Lu B., Rutledge B.J., Gu L., Fiorillo J., and Lukacs N.W. Abnormalities in monocyte recruitment and cytokine expression in monocyte chemoattractant protein 1-deficient mice. J Exp Med 187 (1998) 601-608
19. Luster A.D. Chemokines-chemotactic cytokines that mediate inflammation. N Engl J Med 338 (1998) 436-445
20. Matsumori A., Furukawa Y., Hashimoto T., Yoshida A., Ono K., Shioi T., et al. Plasma levels of the monocyte chemotactic and activating factor/monocyte chemoattractant protein-1 are elevated in patients with acute myocardial infarction. J Mol Cell Cardiol 29 (1997) 419-423
21. McKhann G., Drachman D., Folstein M., Katzman R., Price D., and Stadlan E.M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34 (1984) 939-944
22. Morris J.C., Storandt M., Miller J.P., McKeel D.W., Price J.L., Rubin E.H., et al. Mild cognitive impairment represents early-stage Alzheimer's disease. Arch Neurol 58 (2001) 397-405
23. Morris T.C. Mild cognitive impairment and preclinical Alzheimer's disease. Geriatrics Suppl 1 (2005) 9-14
24. Muessel M.J., Klein R.M., Wilson A.M., and Berman N.E.J. Ablation of the chemokine monocyte chemoattractant protein-1 delays retrograde neuronal degeneration, attenuates microglial activation, and alters expression of cell death molecules. Mol Brain Res 103 (2002) 12-27
25. Pasinetti G.M. Inflammatory mechanisms in neurodegeneration and Alzheimer's disease: the role of the complement system. Neurobiol Aging 17 5 (1996) 707-716
26. Petersen R.C., Smith G.E., Waring S.C., Ivnik R.J., Tangalos E.G., et al. Mild cognitive impairment: clinical characterization and outcome. Arch Neurol 56 (1999) 303-308
27. Petersen R.C., Doody R., Kurz A., Mohs R.C., Morris J.C., Rabins P.V., et al. Current concepts in mild cognitive impairment. Arch Neurol 58 (2001) 1985-1992
28. Petersen R.C. Mild cognitive impairment as a diagnostic entity. J Int Med 256 (2004) 183-194
29. Peterson P.K., Hu S., Salak-Johnson J., Molitor T.W., and Chao C.C. Differential production of and migratory response to beta chemokines by human microglia and astrocytes. J Infect Dis 175 (1997) 478-481
30. Rollins B.J. Monocyte chemoattractanprotein-1: a potential regulator of monocyte recruitment in inflammatory disease. Mol Med Today 2 (1996) 198-204
31. Streit W.J. Microglia and macrophages in the developing CNS. Neurotoxicology 22 (2001) 619-624
32. Sun Y.X., Minthon L., Wallmark A., Warkentin S., Blennow K., and Janciauskiene S. Inflammatory markers in matched plasma and cerebrospinal fluid from patients with Alzheimer's disease. Dement Geriatr Cogn Disord 16 (2003) 136-144
33. Tarkowski E., Andreasen N., Tarkowski A., and Blennow K. Intrathecal inflammation precedes development of Alzheimer's disease. J Neurol Neurosurg Psychiatry 74 (2003) 1200-1205
34. Tarzami S.T., Cheng R., Miao W., Kitsis R.N., and Berman T.W. Chemokine expression inmyocardial ischemia: MIP-2 dependent MCP-1 expression protects cardiomvocvtes from cell death. J Mol Cell Cardiol 34 (2002) 209-221
35. Tassone F., Hagerman R.J., Taylor A.K., Gane L.W., Godfrey T.E., and Hagerman P.J. Elevated levels of FMR1 Mrna in carrier males: a new mechanism of involvement in the Fragile-X Syndrome. Am J Hum Genet 66 (2000) 6-15
36. Teunissen C.E., de Vente J., Steinbusch H.W., and De Bruijn C. Biochemical markers related to Alzheimer's dementia in serum and cerebrospinal fluid. Neurobiol Aging 23 (2002) 485-508
37. Wilms H., Sievers J., Dengler R., Bufler J., Deuschl G., and Lucius R. Intrathecal synthesis of monocyte chemoattractant protein-1 (MCP-1) in amyotrophic lateral sclerosis: further evidence for microglial activation in neurodegeneration. J Neuroimmunol 144 (2003) 139-142
38. Xia M.Q., and Hyman B.T. Chemokines/chemokine receptors in the central nervous system and Alzheimer's disease. J Neurovirol 5 (1999) 32-41